AHA 2023 Insights
Videos
AHA 2023 Insights
AHA 2023 Insights: Contemporary Strategies to Improve the Safety and Efficacy of VT Ablation
FEATURING
Timothy Maher
- 347 views
- December 21, 2023
- 2
AHA 2023 Insights
AHA 2023 Insights: Unloading the Left Ventricle in STEMI - Yes? No? To Be Determined?
FEATURING
Ajar Kochar
- 850 views
- December 19, 2023
- 6
AHA 2023 Insights
AHA 2023 Insights: Rare But Fatal - Thrombus Formation and Cerebral Infarction Following Atrial Fibrillation Ablation
FEATURING
Kunjan Udani
- 540 views
- December 19, 2023
- 2
AHA 2023 Insights
AHA 2023 Insights: Bifurcation Disease - All You Need Is One Stent
FEATURING
Jennifer Rymer
- 1,389 views
- December 1, 2023
- 4
AHA 2023 Insights
AHA 2023 Insights: Multisite and Multipoint Pacing for Heart Failure - Is There Enough Evidence?
FEATURING
Sanjeev Saksena
- 333 views
- December 1, 2023
- 1
AHA 2023 Insights
AHA 2023 Insights: AFib Ablation for Older Adults with HF - Don't Wait, Ablate
FEATURING
Brian Olshansky
- 1,202 views
- November 28, 2023
- 9
AHA 2023 Insights
AHA 2023 Insights: Averaged Impedance Drop Workflow for Pulmonary Vein Isolation
FEATURING
Daniel Friedman
- 229 views
- November 27, 2023
- 2
AHA 2023 Insights
AHA 2023 Insights: Pelvic Vein Compression in Patients Diagnosed With Postural Orthostatic Tachycardia Syndrome
FEATURING
Alexis Cutchins
- 235 views
- November 23, 2023
- 5
AHA 2023 Insights
AHA 2023 Insights: Estimated Lifetime Benefits of SGLT2i, GLP-1 RA and ns-MRA in People with Type 2 Diabetes and Albuminuria
FEATURING
Brendon Neuen
- 192 views
- November 23, 2023
- 3
AHA 2023 Insights
AHA 2023 Insights: Higher Than Daily RDA Recommended Vitamin D3 Dosing and Multiple Titrations Are Required to Achieve >40 ng/mL 25-hydroxy Vitamin D Levels in Acute Coronary Syndrome Participants Enrolled and Randomized to Targeted Vitamin D Treatment - The Target D Trial
FEATURING
Viet Le
- 141 views
- November 23, 2023
AHA 2023 Insights
AHA 2023 Insights: Early Recurrence of Ventricular Tachycardia and the Impact of Radiofrequency Ablation on Success of ICD Therapy
FEATURING
Dalia Giedrimiene
- 137 views
- November 23, 2023
- 1
AHA 2023 Insights
AHA 2023 Insights: Should All Patients Undergoing Pacemaker Implantation Undergo Conduction System Pacing?
FEATURING
Miguel Leal
- 506 views
- November 23, 2023
- 6
AHA 2023 Insights
AHA 2023 Insights: SGLT2 Inhibitors - Clinical Questions for HFpEF That Are Yet to Be Answered Back to the Lab
FEATURING
Joseph Hill
- 641 views
- November 23, 2023
- 8
AHA 2023 Insights
AHA 2023 Insights: Lepodisiran - An Extended-Duration siRNA Targeting Lipoprotein(a)
FEATURING
Steven Nissen
- 2,734 views
- November 22, 2023
- 18
AHA 2023 Insights
AHA 2023 Insights: Comparing the Utility of Remote Monitoring and the Physical Exam in Heart Failure Patients
FEATURING
Eric Adler
- 141 views
- November 22, 2023
- 1
AHA 2023 Insights
AHA 2023 Insights: Reflections on SELECT Trial
FEATURING
Donna Ryan
- 2,092 views
- November 21, 2023
- 11
AHA 2023 Insights
AHA 2023 Insights: Optimizing the Use of SGLT2is, GLP-1 RAs and Non-Steroidal MRAs for Multi-System Benefit
FEATURING
Faiez Zannad
- 1,766 views
- November 21, 2023
- 19
AHA 2023 Insights
AHA 2023 Insights: Inflammation and Cholesterol as Predictors of Cardiovascular Events Among 13.970 Statin-Intolerant Patients
FEATURING
Paul Ridker
- 1,426 views
- November 21, 2023
- 7
AHA 2023 Insights
AHA 2023 Insights: GLP1-RAs - Clinical Indications and Cardiovascular Benefits
FEATURING
Naveed Sattar
- 439 views
- November 21, 2023
AHA 2023 Insights
AHA 2023 Insights: Off-Label Dosing of Direct Oral Anticoagulants Among Inpatients With Atrial Fibrillation
FEATURING
Amneet Sandhu
- 157 views
- November 21, 2023
AHA 2023 Insights
AHA 2023 Insights: Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation - The ARTESIA Trial
FEATURING
Jeffrey Healey
- 3,087 views
- November 21, 2023
- 20
AHA 2023 Insights
AHA 2023 Insights: SGLT2 Inhibitors in Transthyretin Amyloid Cardiomyopathy
FEATURING
Aldostefano Porcari
- 153 views
- November 21, 2023
- 2
AHA 2023 Insights
AHA 2023 Insights: Target-HTN: Trial on the Safety and Efficacy of Lorundrostat (MLS-101) in Patients with Uncontrolled Hypertension
FEATURING
Luke Laffin
- 353 views
- November 20, 2023
- 5